604 completed, 180 unknown, 116 recruiting, 107 terminated. 317 Phase 2, 188 Phase 1, 170 Not applicable, 144 Phase 3, 81 Phase 4.
Follow Uveal Diseases: new trials by email Literature Review of Uveal Diseases trials Research Report on Uveal Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2 - Uveal Melanoma, Metastatic Cutaneous Melanoma | Phase 1 | Not yet recruiting | Vastra Gotaland Region | 6 | 2027-01-31 | 2026-09-09 |
| Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma Autologous Tumor Infiltrating Lymphocytes (TIL), Melphalan, Interleukin-2 - Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma | Phase 1 | Not yet recruiting | Vastra Gotaland Region | 18 | 2027-01-01 | 2026-09-09 |
| Pneumatic Displacement With Anti-VEGF and Concomitant rtPA for PCV-related Submacular Hemorrhage Anti-VEGF agents, tissue plasminogen activator (rtPA), Pneumatic displacement with intravitreal gas - Polypoidal Choroidal Vasculopathy (PCV), Submacular Hemorrhage | Phase 4 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 80 | 2027-01-01 | 2026-11-17 |
| Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial aflibercept 8 mg - Polypoidal Choroidal Vasculopathy, Polypoidal Choroidal Vasculopathy (PCV) | Phase 3 | Recruiting | Yeungnam University College of Medicine | 50 | 2026-12-24 | 2026-02-05 |
| Morpho-functional Evaluation of the Retina and Choroid Using Multimodal Imaging in Healthy Subjects and Patients With Retino-choroidal Diseases Retinal Diseases, Choroidal Diseases | Not yet recruiting | Fondazione G.B. Bietti, IRCCS | 125 | 2026-12-01 | 2026-11-12 | |
| Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research Pericarditis, Tako-TSUBO Cardiomyopathy | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 300 | 2026-12-01 | 2026-11-13 | |
| Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis Blood sample, Adalimumab Injection - Uveitis, Chronic Disease | Phase 4 | Not yet recruiting | Centre Hospitalier Universitaire de Saint Etienne | 320 | 2026-12-01 | 2026-11-19 |
| Gryrotonic Training in Behcet-diseased Elders With Breast Cancer exercise - Breast Cancer, Behcet Disease | Not applicable | Recruiting | Cairo University | 40 | 2026-11-30 | 2026-11-10 |
| Collection and Storage of Biological Samples From Patients Affected by Uveitis for Immunological and Multi-omic Studies Uveitis | Not yet recruiting | IRCCS Ospedale San Raffaele | 200 | 2026-11-30 | 2026-11-16 | |
| Efficacy and Safety of Adalimumab for the Treatment of Ocular Inflammation Adalimumab PFS and Pen - Non-infectious Anterior Uveitis, Non-infectious Intermediate Uveitis | Not applicable | Not yet recruiting | Samsung Medical Center | 40 | 2026-11-15 | 2026-11-09 |
| A Clinical Trial Of Tulisokibart In Participants With Active, Non-Infectious Uveitis (MK-7240-019) Tulisokibart, Placebo, Background prednisone therapy - Noninfectious Intermediate, Posterior, or Panuveitis | Phase 2 | Recruiting | Merck Sharp & Dohme LLC | 87 | 2026-11-04 | 2026-11-16 |
| Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II Valganciclovir, Ganciclovir (GCV), Placebo - Cytomegalovirus (CMV), Anterior Uveitis | Phase 2 | Not yet recruiting | University of California, San Francisco | 117 | 2026-11-01 | 2026-08-11 |
| A Study to Evaluate the Efficacy and Safety of VIS-101 in Participants With Neovascular Age-Related Macular Degeneration VIS-101 6.0mg Low concentration, VIS-101 6.0mg High concentration, VIS-101 9.0mg High concentration - Neovascular Age Related Macular Degeneration(nAMD) | Phase 2 | Not yet recruiting | Everest Medicines (China) Co.,Ltd. | 244 | 2026-11-01 | 2026-11-05 |
| Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With Tebentafusp Dexamethasone - Uveal Melanoma, Metastatic | Phase 2 | Withdrawn | University of California, San Diego | 2026-11-01 | 2026-11-06 | |
| Safety and Efficacy Study in Adults With Advanced Solid Tumors Receiving REGN13089-M404-M2980, an Antibody-drug Conjugate That Targets MET Protein on Tumors REGN13089-M404-M2980 - Advanced Solid Tumors | Phase 1 / Phase 2 | Recruiting | Regeneron Pharmaceuticals | 320 | 2026-10-28 | 2026-11-18 |
| Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma RBP-01 - Uveal Melanoma | Phase 1 / Phase 2 | Not yet recruiting | ReBio Pharma | 30 | 2026-10-01 | 2026-08-05 |
| Clinical, Laboratory, and Therapeutic Analysis of Behçet's Disease in Assiut Behçet's Disease | Not yet recruiting | Assiut University | 30 | 2026-09-30 | 2025-09-05 | |
| Serum EBI-3 Protein Levels in Behçet's Disease Behçet Disease | Not yet recruiting | Assiut University | 90 | 2026-09-26 | 2026-09-28 | |
| Topical Insulin for Glaucoma (TING2) EYED-002 Low Dose (721 U/mL topical insulin), EYED-002 High Dose (1442 U/mL topical insulin), EYED-002 (highest tolerated dose, 12-month) - Open Angle Glaucoma, Primary Open Angle Glaucoma | Phase 1 / Phase 2 | Enrolling by invitation | Stanford University | 90 | 2026-09-10 | 2026-10-13 |
| PANDA-ASOCT: Paediatric Anterior Uveitis Detection With Automated Image Analysis Using ASOCT Slit Lamp Examination, Anterior segment ocular coherence tomography (ASOCT) - Uveitis | Recruiting | Sheffield Children's NHS Foundation Trust | 300 | 2026-09-09 | 2026-09-15 |
Showing 20 of 1157. Sign in to see all of them.
Uveal Melanoma (280) · Uveitis (269) · Choroidal Neovascularization (203) · Macular Degeneration (148) · Behcet Syndrome (132) · Melanoma (125) · Exfoliation Syndrome (72) · Uveitis, Posterior (60) · Uveitis, Intermediate (56) · Macular Edema (54) · Polypoidal Choroidal Vasculopathy (51) · Uveitis, Anterior (48) · Glaucoma, Open-Angle (40) · Panuveitis (38) · Choroideremia (34)
Eye Diseases (1138) · Pathological Conditions, Signs and Symptoms (357) · Pathologic Processes (338) · Choroid Diseases (327) · Neoplasms by Site (293) · Neoplasms by Histologic Type (292) · Skin and Connective Tissue Diseases (289) · Neoplasms, Nerve Tissue (283) · Neuroectodermal Tumors (283) · Neoplasms, Germ Cell and Embryonal (282) · Nevi and Melanomas (282) · Neuroendocrine Tumors (280) · Skin Diseases (279) · Uveal Neoplasms (278)
Ranibizumab (78) · aflibercept (37) · Ipilimumab (30) · Adalimumab (26) · Bevacizumab (26) · Nivolumab (24) · Verteporfin (20) · Triamcinolone Acetonide (18) · Blood Specimen Collection (15) · Cyclophosphamide (15) · Dexamethasone (15) · Methotrexate (15) · pembrolizumab (14) · Interleukin-2 (11) · salicylhydroxamic acid (11)
National Eye Institute (NEI) (58) · Novartis Pharmaceuticals (36) · Assiut University (31) · National Cancer Institute (NCI) (22) · Assistance Publique - Hôpitaux de Paris (17) · Medical University of Vienna (15) · Institut Curie (13) · Memorial Sloan Kettering Cancer Center (11) · Vastra Gotaland Region (11) · Benha University (10) · Novartis (10) · Oregon Health and Science University (10) · M.D. Anderson Cancer Center (9) · Peking Union Medical College Hospital (9) · Sun Yat-sen University (9)
United States (508) · France (120) · Germany (92) · United Kingdom (91) · Spain (69) · China (68) · Italy (67) · Canada (62) · Australia (55) · Turkey (Türkiye) (52) · Austria (44) · Egypt (38) · Israel (38) · Switzerland (38) · South Korea (37)
Hatice N Sen, M.D. (8) · Quan D Nguyen, MD, MSc (6) · Jeffrey S. Weber, MD, PhD (5) · Nisha Acharya, MD MS (5) · Fereydoun Davatchi, MD (4) · Peter A. Merkel, MD, MPH (4) · Thomas Ciulla, MD (4)
PMID 30957581, PMID 37172782, PMID 23290985, PMID 30194931, PMID 30986442, PMID 36787524, PMID 19248087, PMID 19726427, PMID 20498207, PMID 21622969, PMID 21885496, PMID 22426346, PMID 23084240, PMID 24113783, PMID 25667295, PMID 28426849, PMID 28445659, PMID 29528792, PMID 32374423, PMID 33207259, PMID 34968756, PMID 36399237, PMID 36912792, PMID 37316690, PMID 37343623, PMID 38925285, PMID 39033924, PMID 11071039, PMID 11152054, PMID 11153967, PMID 11297486, PMID 11459787, PMID 11468137, PMID 11642370, PMID 11741106, PMID 12039921, PMID 12095806, PMID 12441176, PMID 12459649, PMID 12637048, PMID 12684398, PMID 12707595, PMID 12826605, PMID 12947072, PMID 12967792, PMID 14078870, PMID 14078872, PMID 14557174, PMID 15013874, PMID 15079763
2009 (13), 2019 (8), 2014 (5), 2023 (5), P30CA008748 (4), 2025 (3), N01CM00039 (3), 2008 (2), 2015 (2), 2016 (2), 2017 (2), N01CM00100 (2), N01CM62203 (2), N01CM62206 (2), P30CA006973 (2)